Updated to add comments from Shah Baiju Shah, for years a central public face in Greater Cleveland’s push to build its life science sector, is leaving his post in the region’s key trade group to lead a biotech commercialization project in the city. Shah, the founder and longtime CEO of BioEnterprise, will join BioMotiv, the […]
Health IT in Northeast Ohio could get a boost as life science initiative BioEnterprise introduces a new accelerator for emerging health technology companies. The Health IT Accelerator, announced today by BioEnterprise in partnership with a number of Cleveland healthcare, research, medical payer organizations, will offer mentorship, access to key customers, and business development and fundraising support for area healthcare IT companies with market-ready or in-market products and services.
Munck Wilson Mandala Partner Greg Howison shared his perspective on some of the legal ramifications around AI, IP, connected devices and the data they generate, in response to emailed questions.
The good news for healthcare startups in the Midwest is that they raked in 10 percent more venture capital dollars in 2011 than the prior year. The bad news is that the 2011 total ($810 million) was still less than the amount raised in every year from 2007 to 2009. Venture fundraising by Midwest healthcare […]
It’s probably safe to say that most life sciences startups are familiar with the federal government’s SBIR and STTR programs for funding research. But there are plenty of other federal funding opportunities out there for startups that know where to look. The Department of Defense, in particular, can be a fruitful source of grant funding […]
Minnesota topped all other Midwestern states in attracting investment to healthcare startups during the first half of 2011. Overall, investment in Midwestern healthcare startups was down 24 percent to $315 million, compared with the first half of last year, according to a report from Cleveland-based BioEnterprise, a nonprofit that helps biomedical companies with business development. […]
Midwest healthcare startups raised $737 million last year, a drop of 5 percent from the prior year, according to a report from Cleveland nonprofit biomedical development group BioEnterprise Corp. Biopharmaceutical companies were the top recipients, with 49 percent of the total. Medical device companies raised 38 percent of the total, and health software and services companies collected 14 percent.
At the Abarca Forward conference earlier this year, George Van Antwerp, managing director at Deloitte, discussed how social determinants of health and a personalized member experience can improve medication adherence and health outcomes.
The looming specter of an $8 billion budget deficit will cast its shadow over nearly everything that happens – or doesn't happen – in the Ohio legislature this year. But that won't stop key interest groups from throughout Ohio's healthcare community from pushing for (and against) prospective laws that they hold most (or least) dear.
Investing in health is one of the reasons some are predicting the Midwest will be one of 2011's hottest growth markets for venture capital investing. Through the first three quarters of 2010, the amount of venture money invested in Midwestern startups grew 45 percent to $818 million, according to the National Venture Capital Association. That's a higher amount than Midwestern venture investment in the full year of recession-plagued 2009.
The Ohio division of an international entrepreneurs' group is sponsoring a business plan competition that will award the winner $25,000 in cash and services.
Cleveland is already well-known for its high quality medical care. But its reputation is growing elsewhere. Some of the nation’s best and brightest are flocking to University Circle to be on the cutting edge of the biotech innovation. Channel 3’s Maureen Kyle continues our “Brain Gain” series with a look at how this could be […]
Gabby Everett, the site director for BioLabs Pegasus Park, offered a tour of the space and shared some examples of why early-stage life science companies should choose North Texas.
When it comes to keeping smiles on the faces of Ohio's medical industry leaders, Governor-elect John Kasich's predecessor did him a big favor. It's called Ohio Third Frontier.
2010 may not be the perfect year for private equity investing in healthcare, but it sure beats 2009. That was the consensus among four industry panelists at a Tuesday evening forum sponsored by BioEnterprise, the Cleveland nonprofit economic development group that focuses on growing the region's biomedical industry.
Dr. Raymond Onders will share a venture capital success story this week during his talk, "Helping Patients Breathe: From Superman to Synapse Biomedical -- How orphan diseases can lead to worldwide sales from Northeastern Ohio."
While many college students hope to find a job with any company upon graduation these days, a second-year Case Western Reserve University medical student already has raised $100,000 for his own medical device startup.
Midwestern healthcare startups collectively raised a little more capital in the first half of 2010 than they did in the same period last year. The slight uptick, to $412 million from $403 million, can be attributed in part to increased seed and angel activity, according to (pdf) a statement from Cleveland-based nonprofit BioEnterprise, which tracks […]